Skip to main content

Table 5 Linear regression model of pre-bronchodilator predicted FEV 1 %, FVC% and FEV 1 /FVC ratio in asthmatic women; HUGG, 2013–2014

From: Central obesity and other factors associated with uncontrolled asthma in women

  

FEV 1 % predicted

FVC % predicted

FEV 1 /FVC

Variable

Category or increment

Model 1* β (95% CI)

p

Model 2** β (95% CI)

p

Model 3*** β (95% CI)

p

Central

Normal

Baseline

0.20

Baseline

0.02

Baseline

0.57

Obesity

>88 cm

−5.67 (−14.48 to 3.13)

−8.98 (−16.75 to −1.20)

1.51 (−3.82to 6.85)

Age

Years

−0.39 (−0.73 to 0.60)

0.02

−0.43 (−0,73 to −0,14)

0.00

−0.03 (−0.23 to 0.17)

0.75

Education Level

>4 years

Baseline

0.68

Baseline

0.46

Baseline

0.99

 

≤4 years

−1.76 (−10.20 to 6.68)

−2.72 (−10.14 to 4.69)

−0.02 (−5.14 to 5.09)

Age of Onset

≤12years

Baseline

0.82

Baseline

0.43

Baseline

0.36

 

>12years

1.46 (−11.42 to 14.36)

4.46 (−6,.89 to 15.81)

−3.61 (−11.42 to 4.20)

Disease Duration

Years

−0.07 (−0.40 to 0.25)

0.65

0.16 (−0.13 to 0.45)

0.27

−0,23 (−0.43 to −0.03)

0.02

  1. *Model 1: Linear regression model pre-bronchodilator predicted FEV1%.
  2. R2:0,075.
  3. **Model 2: Linear regression model of pre-bronchodilator predicted FVC%.
  4. R2:0,107.
  5. ***Model 3: Linear regression model of pre-bronchodilator FEV1/FVC ratio.
  6. R2:0,032.
  7. Central obesity defined according to WC.